Free Trial

Inotiv (NOTV) Stock Forecast & Price Target

Inotiv logo
$1.78
+0.01 (+0.56%)
(As of 11/1/2024 ET)

Inotiv - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
2

Based on 3 Wall Street analysts who have issued ratings for Inotiv in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for NOTV.

Consensus Price Target

$5.92
232.40% Upside
According to the 3 analysts' twelve-month price targets for Inotiv, the average price target is $5.92. The highest price target for NOTV is $10.00, while the lowest price target for NOTV is $3.75. The average price target represents a forecasted upside of 232.40% from the current price of $1.78.
Get the Latest News and Ratings for NOTV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Inotiv and its competitors.

Sign Up

NOTV Analyst Ratings Over Time

TypeCurrent Forecast
11/3/23 to 11/2/24
1 Month Ago
10/4/23 to 10/3/24
3 Months Ago
8/5/23 to 8/4/24
1 Year Ago
11/3/22 to 11/3/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.92$5.92$5.25$15.25
Forecasted Upside232.40% Upside200.34% Upside214.37% Upside742.54% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Moderate Buy

NOTV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NOTV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Inotiv Stock vs. The Competition

TypeInotivMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.79
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside232.40% Upside15,872.23% Upside10.57% Upside
News Sentiment Rating
Neutral News

See Recent NOTV News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/30/2024Lake Street Capital
3 of 5 stars
F. Takkinen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$2.00 ➝ $4.00+128.57%
5/16/2024Craig Hallum
3 of 5 stars
 Lower TargetBuy ➝ Buy$25.00 ➝ $10.00+373.93%
5/14/2024Jefferies Financial Group
2 of 5 stars
 DowngradeBuy ➝ Hold$11.50 ➝ $3.75-10.07%
7/20/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$9.00+77.51%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:29 PM ET.


NOTV Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Inotiv is $5.92, with a high forecast of $10.00 and a low forecast of $3.75.

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inotiv in the last year. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NOTV shares.

According to analysts, Inotiv's stock has a predicted upside of 232.40% based on their 12-month stock forecasts.

Over the previous 90 days, Inotiv's stock had 1 upgrade by analysts.

Inotiv has been rated by research analysts at Lake Street Capital in the past 90 days.

Analysts like Inotiv less than other "medical" companies. The consensus rating score for Inotiv is 2.67 while the average consensus rating score for "medical" companies is 2.79. Learn more on how NOTV compares to other companies.


This page (NASDAQ:NOTV) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners